• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘是否是中国 SARS-CoV-2 感染的排除条件?——哮喘与 COVID-19 的关系。

Is asthma an exclusionary condition for SARS-CoV-2 infection in China? -the relationship between asthma and COVID-19.

机构信息

Respiratory Department, Qilu Children's Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China.

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, PR China.

出版信息

J Asthma. 2021 Oct;58(10):1337-1339. doi: 10.1080/02770903.2020.1789873. Epub 2020 Aug 4.

DOI:10.1080/02770903.2020.1789873
PMID:32600166
Abstract

OBJECTIVE

To investigate the relationship between asthma and COVID-19.

METHODS

We searched the existing literature and researches to analyze the possible reasons.

RESULTS

The possible reasons for the very low COVID-19 infection in asthma patients in China may be as follows: the expression of ACE2 in asthma patients is relatively low; the use of ICS in asthma patients may have protective effect; data bias and ethnic differences are also possible reasons, too.

CONCLUSION

The relationship between asthma patients and COVID-19 has not been completely clear, which needs further study.

摘要

目的

研究哮喘与 COVID-19 的关系。

方法

我们检索了现有文献和研究,以分析可能的原因。

结果

中国哮喘患者 COVID-19 感染率极低的可能原因如下:哮喘患者 ACE2 表达相对较低;哮喘患者使用 ICS 可能具有保护作用;数据偏差和种族差异也可能是原因之一。

结论

哮喘患者与 COVID-19 的关系尚未完全明确,需要进一步研究。

相似文献

1
Is asthma an exclusionary condition for SARS-CoV-2 infection in China? -the relationship between asthma and COVID-19.哮喘是否是中国 SARS-CoV-2 感染的排除条件?——哮喘与 COVID-19 的关系。
J Asthma. 2021 Oct;58(10):1337-1339. doi: 10.1080/02770903.2020.1789873. Epub 2020 Aug 4.
2
Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.哮喘相关细胞因子调节哮喘患者肺部组织中 SARS-CoV-2 受体 ACE2 的表达。
Front Immunol. 2022 Jan 17;12:796094. doi: 10.3389/fimmu.2021.796094. eCollection 2021.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.血管紧张素转换酶2(ACE2)受体、哮喘与严重新型冠状病毒肺炎感染风险
Eur Ann Allergy Clin Immunol. 2020 Nov;52(6):282-285. doi: 10.23822/EurAnnACI.1764-1489.169. Epub 2020 Nov 3.
5
Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.抗 TNF-α 药物通过 Notch-1 信号调节 SARS-CoV-2 受体并增加感染风险。
Front Immunol. 2021 May 6;12:641295. doi: 10.3389/fimmu.2021.641295. eCollection 2021.
6
Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.大鼠上下呼吸道中 ACE2 和 TMPRSS2 蛋白的表达:对 COVID-19 感染的影响。
Laryngoscope. 2021 Mar;131(3):E932-E939. doi: 10.1002/lary.29132. Epub 2020 Oct 19.
7
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号,导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
8
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.在健康人群以及哮喘、COPD、肥胖、高血压和 COVID-19 危险因素患者的组织和免疫细胞中,ACE2、CD147、CD26 和其他 SARS-CoV-2 相关分子的分布。
Allergy. 2020 Nov;75(11):2829-2845. doi: 10.1111/all.14429. Epub 2020 Aug 24.
9
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.几种膜结合丝氨酸蛋白酶对 SARS-CoV-2 S 蛋白的启动作用可以解释增强的病毒感染力和全身性 COVID-19 感染。
J Biol Chem. 2021 Jan-Jun;296:100135. doi: 10.1074/jbc.REV120.015980. Epub 2020 Dec 6.
10
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.SARS-CoV-2 人类靶标在肿瘤和非肿瘤肺组织中的表达及临床意义。
Curr Cancer Drug Targets. 2021 Jul 5;21(5):428-442. doi: 10.2174/1568009620666201207145019.

引用本文的文献

1
Facts and Challenges about Asthma and COVID-19 among the Paediatric Population: A Systematic Literature Review.儿科人群哮喘和 COVID-19 的现状和挑战:系统文献综述。
Medicina (Kaunas). 2021 Nov 29;57(12):1306. doi: 10.3390/medicina57121306.
2
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.成人 COVID-19 患者中的哮喘。患病率和严重疾病风险。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):893-905. doi: 10.1164/rccm.202008-3266OC.
3
Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019.
人畜共患冠状病毒流行:严重急性呼吸综合征、中东呼吸综合征和 2019 年冠状病毒病。
Ann Allergy Asthma Immunol. 2021 Apr;126(4):321-337. doi: 10.1016/j.anai.2020.11.021. Epub 2020 Dec 11.